Shanghai Jmt-bio Inc.
Clinical trials sponsored by Shanghai Jmt-bio Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug JMT206 tested for safety in first human trial Results expected Sep 2026 (estimated)
- New hope for advanced cancer? JMT106 injection enters first human trial Results expected Nov 2026 (estimated)
- New shot JMT108 targets tough melanoma in early trial Results expected Nov 2026 (estimated)
- New two-drug combo aims to wipe out HER2 breast cancer before surgery Results expected Dec 2026 (estimated)
- New hope for HER2+ breast cancer: experimental drug JSKN003 faces off against standard therapy Results expected May 2027 (estimated)